Global Regulatory Expertise Syner-G operates across North America, Europe and APAC with 400+ professionals, offering integrated scientific, regulatory, technical and strategic consulting throughout the development lifecycle, enabling multi region IND to NDA programs and regulatory filings.

AI Driven Capabilities With the launch of 3D Intelligence in 2026 and a partnership with Weave for AI augmented authoring, Syner-G signals a strategic shift toward AI and data driven workflows; this creates opportunities to offer AI enabled submission automation, knowledge management, and digital transformation services to biotech sponsors.

Growth and Acquisitions The 2024 merger, 2023 acquisition of RMC and 2025 senior hires demonstrate a growth oriented, integrated services model; this creates cross sell opportunities across combined capabilities and stronger program management for expanding biotech portfolios.

Leadership and Talent Leadership hiring and industry recognition as a best place to work point to a strong talent engine; this can be leveraged to offer staff augmentation, clinical operations support, and scalable teams to meet sponsor demand during peak development.

Mid Size Position With revenue in the 50 to 100 million range and more than 400 professionals, Syner-G sits as a mid size, full service partner against mid tier CROs; target mid sized biotech sponsors seeking end to end development, risk reduction, and faster timelines, offering a one stop partner to consolidate vendors.